单位:[1]Department of Clinical Laboratory Diagnostics, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China医技科室检验科检验科首都医科大学附属北京友谊医院[2]Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA[3]Department of Obstetrics and Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 201204, China[4]Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138, USA
The correlation between P-glycoprotein (Pgp) overexpression and multidrug resistance (MDR) in cancer is well-established. Recently, we identified (2-(4-methoxyphenyl)-4-quinolinyl) (2-piperidinyl)methanol (5) (NSC23925) as the most selective and potent MDR inhibitor. NSC23925 binds to Pgp, thus inhibiting its transporter function and reversing MDR in cancer cells. In order to further characterize the chemical properties and Pgp binding mode of the NSC23925 compound, we grew four NSC23925 crystal isomers (NSC23925a, NSC23925b, NSC23925c, and NSC23925d). These crystal isomers were first generated using a vapor diffusion growth technique before their precise structures were analyzed using X-ray crystal-lography. Functionally, the NSC23925a and NSC23925b isomers share a similar stabilization interaction of Cl- mediated hydrogen bonding. In contrast, in isomer NSC23925c, two Cl- are involved in the stabilization of adjacent molecules. In summary, these solved crystal structures may reveal the different activities of the four NSC23925 stereoisomers. (C) 2019 Elsevier B.V. All rights reserved.
基金:
Gattegno and Wechsler funds; Sarcoma Foundation of America (SFA); National Cancer Institute (NCI, National Institutes of Health (NIH))United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA 151452]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81802064, 81602278]
第一作者单位:[1]Department of Clinical Laboratory Diagnostics, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China[2]Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Gao Yan,Xi Weixian,Yang Xiaoqian,et al.Crystallization and characterization of small molecular multidrug resistance inhibitor targeting P-glycoprotein, NSC23925 isomers[J].JOURNAL of MOLECULAR STRUCTURE.2019,1193:7-13.doi:10.1016/j.molstruc.2019.05.010.
APA:
Gao, Yan,Xi, Weixian,Yang, Xiaoqian,Dean, Dylan C.,Zheng, Shao-Liang...&Duan, Zhenfeng.(2019).Crystallization and characterization of small molecular multidrug resistance inhibitor targeting P-glycoprotein, NSC23925 isomers.JOURNAL of MOLECULAR STRUCTURE,1193,
MLA:
Gao, Yan,et al."Crystallization and characterization of small molecular multidrug resistance inhibitor targeting P-glycoprotein, NSC23925 isomers".JOURNAL of MOLECULAR STRUCTURE 1193.(2019):7-13